Sulfonylureas and ischaemic preconditioning. A double-blind, placebo-controlled evaluation of glimepiride and glibenclamide

European Heart Journal

Volumn 20, Issue 6, 1999, Pages 439-446

  Klepzig, H ^a   Kober, G ^b   Matter, C ^c   Luus, H ^d   Schneider, H ^a   Boedeker, K H ^b   Kiowski, W ^c   Amann, F W ^c   Gruber, D ^a   Harris, S ^d   Burger, W ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Klinik Nordrhein   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

Glibenclamide; Glimepiride; Ischaemic preconditioning; Percutaneous transluminal coronary angioplasty

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; GLIMEPIRIDE; POTASSIUM CHANNEL; SULFONYLUREA;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART INFARCTION PREVENTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING; MALE; MIDDLE AGED; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 0032972077     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1242     Document Type: Article

References (34)

1. Dräger E. Clinical profile of glimepiride. Diabetes Res Clin Pract. 28:1995;139-146.
2. Diabetes. 19:1970;787-830.
3. Lomuscio A, Vergani D, Marano L, Castagnone M, Fiorentini C. Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction. Cor Art Dis. 5:1994;767-771.
4. +. Circ Res. 66:1990;478-485.
5. Billman GE, Avendano CE, Halliwill JR, Burroughs JM. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs. J Cardiovasc Pharmacol. 21:1993;197-204.
6. Daut J, Maier-Rudolph W, von Beckerath, Mehrke G, Günther K, Goedel-Meinen L. Hypoxic dilatation of coronary arteries is mediated by ATP-sensitive potassium channels. Science. 247:1990;1341-1344.
7. Auchampach JA, Maruyama M, Cavero I, Gross GJ. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation. 86:1992;311-319.
8. +. Circ Res. 69:1991;571-581.
9. +. Circulation. 90:1994;700-705.
10. Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P. Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous trans-luminal coronary angioplasty. Circulation. 74:1986;330-339.
11. Kober G, Kästner R, Hopf R, Kaltenbach M. Die direkte myokardiale antiischämische Wirkung von Diltiazem beim Menschen. Z Kardiol. 75:1986;386-393.
12. Kober G, Buck T, Sievert H, Vallbracht C. Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine. Eur Heart J. 13:1992;1109-1115.
13. Sievert H, Friedmann A, Schräder R, Kaltenbach M, Kober G. Untersuchungen zum Einfluß des Kalzium-antagonisten Nisoldipin auf den koronaren Blutfluß und die Myokardischämie bei temporärer Koronarokklusion. Z Kardiol. 79:1990;683-688.
14. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
15. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol. 24:1994;1133-1142.
16. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Hermann HC, Laskey K. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation. 82:1990;2044-2051.
17. Cribier A, Korsatz L, Koning R. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol. 20:1992;578-586.
18. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation. 91:1995;291-297.
19. Marber MS, Baxter GF, Yellon DM. Prodromal angina limits infarct size. Letter to the editor. Circulation. 92:1995;1061-1062.
20. 1. Circulation. 86:1992;1310-1316.
21. +. Nature. 305:1983;147-148.
22. +. Br J Pharmacol. 103:1991;1019-1026.
23. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultra-structural damage during a sustained ischemic episode. Circ Res. 66:1990;913-931.
24. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res. 27:1993;617-622.
25. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 70:1992;223-233.
26. Müller G, Satoh Y, Geissen K. Extrapancreatic effects of sulfonylureas-a comparison between glimepiride and conventional sulfonylureas. Diabetes Res Clin Pract. 28:1995;S115-S137.
27. Müller G, Hartz D, Pünter J, Ökonomopulos R, Kramer W. Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor. I. Binding characteristics. Biochim Biophys Acta. 1191:1994;267-277.
28. Imamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol. 263:1992;H399-H404.
29. Schulz R, Rose J, Martin C, Heusch G. Activation of ATP-dependent potassium channels is involved in ischemic pre-conditioning in swine (Abstr). Circulation. 88:1993;I-102.
30. +. Circulation. 88:1993;1845-1851.
31. Kondo T, Kubota I, Tachibana H, Yamaki M, Tomoike H. Glibenclamide attenuates peaked T wave in early phase of myocardial ischemia. Cardiovasc Res. 31:1996;683-687.
32. 2+. Circulation. 92:1995;1597-1603.
33. Cacciapuoti F, Spiezia R, Bianchi U, Lama D, D'Avino M, Varricchio M. Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus. Am J Cardiol. 67:1991;843-847.
34. Okishige K, Yamashita K, Yoshinaga H. Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty. J Am Coll Cardiol. 28:1996;70-73.